**Core Concept**
High oral to parenteral activity ratio refers to the phenomenon where a drug exhibits a higher therapeutic effect when administered orally compared to intravenously. This is often due to the drug's ability to undergo first-pass metabolism in the liver after oral administration, resulting in a lower bioavailability.

**Why the Correct Answer is Right**
The correct answer is related to the concept of **first-pass metabolism**. When a drug is administered orally, it is absorbed into the portal circulation and passes through the liver before reaching the systemic circulation. This can lead to a significant decrease in the drug's bioavailability due to metabolism by liver enzymes, such as cytochrome P450. However, if the drug is administered parenterally (e.g., intravenously), it bypasses the liver and is delivered directly to the systemic circulation, resulting in a higher bioavailability.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not describe a characteristic of high oral to parenteral activity ratio.
**Option B:** This option is incorrect because it is not related to the concept of first-pass metabolism and high oral to parenteral activity ratio.
**Option C:** This option is incorrect because it is a general term and does not specifically describe the phenomenon of high oral to parenteral activity ratio.

**Clinical Pearl / High-Yield Fact**
A high oral to parenteral activity ratio is often seen with drugs that are substrates for the enzyme **CYP3A4**, which is involved in the metabolism of many lipophilic drugs.

**Correct Answer:** D.